cbdMD Closes Twinlab Asset Acquisition; Pays 2.23M Shares Plus $1.75M Secured Note
YCBD sits 23% above its 52-week low of $0.33.
Summary
cbdMD completed its acquisition of Twinlab's operating assets and brands, paying 2,229,805 shares valued at $1.00 each plus a $1,750,000 9% secured note, with 132,730 more shares subject to shareholder approval.
Key Events · M&A and Partnerships · YCBD
-
Twinlab Acquisition Closed
On October 30, 2026, cbdMD, through subsidiary To Be Brands, LLC, completed the purchase of Twinlab's operating assets and the Twinlab, Reserveage, Metabolife and ResVitale brands out of a Florida assignment-for-benefit-of-creditors proceeding.
-
Stock Consideration Issued
2,229,805 shares were issued to secured creditor Akretive Holdings at a stated $1.00 per share, equal to 19.9% of shares outstanding at the APA execution date; 132,730 additional shares require shareholder approval, which the company must seek within 270 days.
-
New $1.75M Secured Note
The acquisition sub and acquired subsidiaries issued a $1,750,000 senior secured note at 9% interest maturing two years after closing, secured by the acquired assets, with a working-capital facility permitted to rank ahead of it.
-
Resale Registration Due
cbdMD agreed to file a registration statement covering resale of the consideration shares within nine months of closing, subject to leak-out restrictions.
Analysis · YCBD · Industrial Applications And Services
The Twinlab asset purchase cbdMD announced September 2 has closed, adding the Twinlab, Reserveage, Metabolife and ResVitale brands and moving the business beyond hemp. Consideration is now quantified: 2,229,805 shares issued to secured creditor Akretive at a stated $1.00 per share — roughly 2.5x today's $0.406 quote — plus a $1,750,000 9% senior secured note maturing in two years and secured by the acquired assets. Another 132,730 shares hinge on a shareholder vote the company must pursue within 270 days, and a resale registration is due within nine months, positioning the new holders' stock to trade. For a company this small, the deal is transformative on revenue mix but adds real leverage and a large new block of shares.
How filings like this one have moved
In the 30 days to Nov 4, 2026, 41.6% of the 1192 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.37%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, YCBD was trading at $0.41 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.5M. The 52-week trading range was $0.33 to $2.56. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.